Novo Nordisk A/S expects generic Ozempic to be delayed in China until next year, a positive step for the drugmaker as it battles to keep its share of the global obesity market. For the full story, visit the source.
Business
Novo Sees Generic Ozempic Delayed in China Until Next Year
Novo Nordisk A/S expects generic Ozempic to be delayed in China until next year, a positive step for the drugmaker as it battles to keep its share of the global obesity market.
By Bloomberg News· Financial Post· 3 days ago· 2 min read
This summary is sourced from Financial Post. Read the full article at:Financial Post